In the rapidly evolving realm of technology and intellectual property, Apple has become entangled in a multifaceted legal dispute surrounding its smartwatches’ blood-oxygen monitoring feature. This unfolding drama takes center stage as the tech giant grapples with issues of innovation, regulatory compliance, and intellectual property rights in a case brought forth by Masimo Corp.